A summary of Q4 2024 earnings call transcripts from various companies including Oxford Nanopore, NeuroPace, Stem, OrthoPediatrics, Ingram Micro, and Cryoport, highlighting key insights. Read more...
A look at several stocks in the news: high-yield options, AstraZeneca's blue-chip status, Live Nation's valuation, W.P. Carey's performance, and an energy fund navigating price uncertainty. Read more...